Journal Menu
- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Glucagon-Like Peptide-1 and Diabetes
Guest Editors: Matteo Monami, Giovanni Di Pasquale, Edoardo Mannucci, and Carlo Maria Rotella- Glucagon-Like Peptide-1 and Diabetes, Matteo Monami
Volume 2011 (2011), Article ID 901954, 1 page - Subthreshold α2-Adrenergic Activation Counteracts Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion, Minglin Pan, Guang Yang, Xiuli Cui, and Shao-Nian Yang
Volume 2011 (2011), Article ID 604989, 7 pages - Erratum to “Subthreshold α2-Adrenergic Activation Counteracts Glucagon-Like Peptide-1 Potentiation of Glucose-Stimulated Insulin Secretion”, Minglin Pan, Guang Yang, Xiuli Cui, and Shao-Nian Yang
Volume 2011 (2011), Article ID 319202, 1 page - Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass, Bernard Portha, Cécile Tourrel-Cuzin, and Jamileh Movassat
Volume 2011 (2011), Article ID 376509, 11 pages - Assessment of Glucagon-Like Peptide-1 Analogue and Renin Inhibitor on the Binding and Regulation of GLP-1 Receptor in Type 1 Diabetic Rat Hearts, Shushan B. Artinian, Sawsan M. Al Lafi, Suzan S. Boutary, Khalil M. Bitar, Nadine S. Zwainy, and Anwar B. Bikhazi
Volume 2011 (2011), Article ID 489708, 7 pages - Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function, Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, and Michael Horowitz
Volume 2011 (2011), Article ID 279530, 10 pages - From Theory to Clinical Practice in the Use of GLP-1 Receptor Agonists and DPP-4 Inhibitors Therapy, Ilaria Dicembrini, Laura Pala, and Carlo Maria Rotella
Volume 2011 (2011), Article ID 898913, 8 pages - Glucagon-Like Peptide-1, Diabetes, and Cognitive Decline: Possible Pathophysiological Links and Therapeutic Opportunities, Enrico Mossello, Elena Ballini, Marta Boncinelli, Matteo Monami, Giuseppe Lonetto, Anna Maria Mello, Francesca Tarantini, Samuele Baldasseroni, Edoardo Mannucci, and Niccolò Marchionni
Volume 2011 (2011), Article ID 281674, 6 pages - Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events: A Meta-Analysis of Randomized Clinical Trials, Matteo Monami, Francesco Cremasco, Caterina Lamanna, Claudia Colombi, Carla Maria Desideri, Iacopo Iacomelli, Niccolò Marchionni, and Edoardo Mannucci
Volume 2011 (2011), Article ID 215764, 10 pages - Glucagon-Like Peptide-1 Gene Therapy, Anne M. Rowzee, Niamh X. Cawley, John A. Chiorini, and Giovanni Di Pasquale
Volume 2011 (2011), Article ID 601047, 5 pages